CRISPR

A DCI research team has found a new way to identify diverse CRISPR RNA variants that can specifically home in on challenging areas of DNA to target for editing.

Kris Wood, PhD, and colleagues have discovered a potential new drug therapy for leukemia that's preparing to enter clinical trials.

Dukes receives two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Function (IGVF) Consortium.

Research led by DCI member David Sherwood, PhD, may help pinpoint what might be going wrong in human diseases ranging from kidney disease to invasive cancer.

Funding from the Elsa U. Pardee Foundation will allow investigator to study muscle regeneration and cancer.

Scott Soderling, PhD, has founded a Duke spinout company based on a technology developed in his lab that uses the genome-editing tool CRISPR.